"Vecuronium Bromide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.
| Descriptor ID |
D014673
|
| MeSH Number(s) |
D04.210.500.054.040.920
|
| Concept/Terms |
Vecuronium Bromide- Vecuronium Bromide
- Bromide, Vecuronium
- Vecuronium Hydrobromide
- Hydrobromide, Vecuronium
NC-45- NC-45
- NC 45
- NC45
- ORG-NC45
- ORG NC45
- ORG-NC 45
- ORG NC 45
- ORGNC 45
- ORG-NC-45
- ORGNC45
|
Below are MeSH descriptors whose meaning is more general than "Vecuronium Bromide".
Below are MeSH descriptors whose meaning is more specific than "Vecuronium Bromide".
This graph shows the total number of publications written about "Vecuronium Bromide" by people in this website by year, and whether "Vecuronium Bromide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vecuronium Bromide" by people in Profiles.
-
Practice Change From Intermittent Medication Boluses to Bolusing From a Continuous Infusion in Pediatric Critical Care: A Quality Improvement Project. Pediatr Crit Care Med. 2018 06; 19(6):572-577.
-
Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review. South Med J. 1997 Aug; 90(8):769-74.
-
Resistance to vecuronium in patients with cerebral palsy. Anesth Analg. 1991 Sep; 73(3):275-7.